🔗 Share this article

A shadow market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Via Social Media

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust trade exists on messaging services, where communities with thousands of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting products of uncertain source.

Several professionals stated the demand for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach medicines, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Content Removal

Based on the social media company, the platform has taken down problematic material and banned related hashtags and search suggestions. The organization stated it was committed to keeping the platform secure and investing in enhancing compliance measures.

Digital Trading Operations

Research also found groups with up to 9,000 participants selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, positive testimonials and step-by-step guides for mixing or administering at home.

Within minutes of joining one group, a vendor posted WhatsApp details, where most transactions occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, health issues or past usage.

Item Information and Costs

Inside these groups, messages display dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When asked how long a injector should last, vendors give conflicting responses varying between a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it actively monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company investigational product not yet approved … may subject patients to potentially serious medical dangers”.